Stock Events

Stock Events

Medpace 

€366.2
245
+€11.2+3.15% Tuesday 19:55

Statistics

Day High
369.1
Day Low
350
52W High
555
52W Low
253.5
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27JulExpected
Q4 2025
Q1 2026
Next
3.35
3.54
3.73
3.92
Expected EPS
3.39764769006
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 01P.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
IQVIA
IQV
Mkt Cap26.48B
IQVIA provides similar contract research services, making it a direct competitor in the pharmaceutical and biotech industry.
Charles River Laboratories International
CRL
Mkt Cap8.18B
Charles River Laboratories offers a broad range of preclinical and clinical laboratory services, directly competing with Medpace's research services.
Icon Energy
ICON
Mkt Cap3.63M
ICON plc provides clinical research services across a wide range of therapeutic areas, competing directly with Medpace in the CRO space.
Evolent Health
EVH
Mkt Cap427.57M
Evolent Health offers services that, while more focused on healthcare delivery and payment, indirectly compete with Medpace in the broader healthcare services market.

About

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Employees
5000
Country
United States
ISIN
US58506Q1094

Listings

MI
IT
1MEDP.MI
MU
DE
01P.MU
STU
DE
01P.STU
BOATS
BOATS
MEDP.BOATS

0 Comments

Share your thoughts

FAQ

What is Medpace stock price today?▼
The current price of 01P.STU is €366.2 EUR — it has increased by +3.15% in the past 24 hours. Watch Medpace stock price performance more closely on the chart.
What is Medpace stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medpace stocks are traded under the ticker 01P.STU.
Is Medpace stock price growing?▼
01P.STU stock has risen by +3.62% compared to the previous week, the month change is a -14.88% fall, over the last year Medpace has showed a +44.46% increase.
When is the next Medpace earnings date?▼
Medpace is going to release the next earnings report on July 27, 2026.
What were Medpace earnings last quarter?▼
01P.STU earnings for the last quarter are 3.66 EUR per share, whereas the estimation was 3.35 EUR resulting in a +9.17% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Medpace have?▼
As of May 06, 2026, the company has 5,000 employees.
In which sector is Medpace located?▼
Medpace operates in the Health & Wellness sector.
When did Medpace complete a stock split?▼
Medpace has not had any recent stock splits.
Where is Medpace headquartered?▼
Medpace is headquartered in Cincinnati, United States.